Microbot Medical Inc. (MBOT) recently announced a Phase 2 collaboration agreement with Corewell Health. Under the agreement, both companies will work together to develop the capabilities to perform simulated cardiovascular interventional procedures with LIBERTY — an endovascular robotic surgical system. The agreement followed the successful completion of Phase 1, which showed LIBERTY's technical capabilities and outlined potential future applications in various endovascular interventions. Phase 1 evaluated ...